Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
49.20    0.00 (0.00%)
Bid:
48.40
Ask:
50.00
Spread: 1.60 (3.306%)
Market Cap: £188.02m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

1st Quarter Results

16 Jun 2023 12:00

RNS Number : 0282D
British Smaller Companies VCT2 Plc
16 June 2023
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2023

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2023. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

In the quarter to 31 March 2023, the Company generated a 1.0 per cent return on its opening Net Asset Value of 61.6 pence, compared to a 1.9 per cent fall in the FTSE Small Cap. AIC data ranks the Company second across all generalist VCTs when considering a blended average performance ranking over 1, 3, 5 and 10 years.

The Company's Total Return at 31 March 2023 was up 0.6 pence at 143.2 pence per ordinary share.

During the quarter, the Company invested £2.4 million into new investment DrDoctor, a patient engagement and communications software platform; and £1.2 million into new investment Xapien, an AI-powered software platform that fully automates detailed background research on individuals and companies. The Company has also invested a further £1.6 million into Quality Clouds, to provide the runway and resources to accelerate the company's sales growth.

Following the quarter end, one follow-on investment totalling £0.5 million into Relative Insight has been completed, taking the total invested in the current financial year to £5.7 million, following the £16.3 million invested in 2022.

The Company realised its investment in Wakefield Acoustics in January 2023, generating proceeds of £0.6 million and an overall return of 1.5x cost. Subsequent to the quarter end, the Company realised its investment in Ncam, in line with the valuation at 31 March 2023, with initial proceeds of £0.9 million being received.

 

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

 

31 December 2022

Increase in Value

Dividends paid/shares issued

Buyback of shares

Movement

in Period

31 March 2023

Net Assets (£m)

111.9

1.0

(3.3)

(0.3)

(2.6)

109.3

NAV per share (PPS)

61.6p

0.6p

(2.25p)

-

(1.65p)

59.95p

Cumulative dividends paid (PPS)

81.0p

-

2.25p

-

-

83.25p

Total Return (PPS)

142.6p

0.6p

-

-

0.6p

143.2p

Shares in issue

181,468,710

-

1,427,418

(552,351)

875,067

182,343,777

The unaudited NAV per ordinary share was down 1.65 pence at 59.95 pence per share (31 December 2022: 61.6 pence per ordinary share), following the dividend of 2.25 pence per share paid on 11 January 2023.

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 31 December 2022

111.9

61.6

Increase in portfolio value

1.5

0.8

Net operating costs

(0.5)

(0.2)

1.0

0.6

Issue/buy-back of shares

0.5

-

Total Return in the period

1.5

0.6

NAV before the payment of dividends

113.4

62.2

Dividends paid

(4.1)

(2.25)

NAV at 31 March 2023

 

109.3

 

59.95

Buybacks, dividends and shares in issue

On 28 March 2023, the Company purchased 552,351 ordinary shares of 10 pence each at a price of 56.88 pence per ordinary share. These shares were placed in treasury.

Following payment of the special dividend for the year ending 31 December 2023 of 2.25 pence per ordinary share on 11 January 2023, the Company issued 1,427,418 ordinary shares under the DRIS, taking cumulative dividends paid to 83.25 pence per ordinary share.

The number of ordinary shares in issue at 31 March 2023 was 182,343,777 (31 December 2022: 181,468,710). In addition, at 31 March 2023 the Company held 19,219,163 ordinary shares in treasury (31 December 2022: 18,666,812).

Following the successful fundraising, the Company issued 46,357,328 ordinary shares of 10 pence each on 4 April 2023, taking the number of shares in issue to 228,701,105 ordinary shares with voting rights.

The Board has approved an interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2023, which will be paid on 26 June 2023 to those shareholders on the Company's register at the close of business on 12 May 2023.

Net assets

Net assets at 31 March 2023 comprised the following:

£000

% of net assets

Unquoted investments at fair value

87,428

80.0

Listed investment funds

1,504

1.4

Cash and cash equivalents

19,993

18.3

Other net current assets

383

0.3

Net assets

109,308

100.0

 

Investments

The investment portfolio at 31 March 2023 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

21,281

19.5%

Unbiased

6,652

25.6%

Outpost

6,280

31.3%

Wooshii

4,761

35.7%

Displayplan

4,254

39.5%

Elucidat

4,184

43.4%

ACC Aviation

3,614

46.7%

Force24

3,172

49.6%

Quality Clouds

2,716

52.1%

Vypr

2,701

54.5%

59,615

54.5%

Other investments

27,813

80.0%

Total investments

87,428

80.0%

Shareholder relations

An in-person Shareholder Workshop will be held on Tuesday 2o June 2023 at 1 Great George Street, Westminster, London SW1P 3AA. Please email Tracey Nice at Tracey.nice@yfmep.com for further information.

Fundraising

On 4 April 2023, the Company allotted shares from its fully subscribed 2022/23 share offer. £27.5 million was raised by the Company, resulting in the allotment of 46,357,328 ordinary shares. This increased the number of ordinary shares issued with voting rights to 228,701,105.

Outlook

The economic environment remains challenging; while energy prices and inflation are moving down from peaks, these remain high, keeping interest rates elevated. This has fed through to valuation multiples, which remain dampened. In this environment, the portfolio continues to be robust, with the Company's performance buoyed by positive uplifts when exiting investments and continued revenue growth from existing investments.

There continues to be a good pipeline of new companies seeking investment, and the opportunity to deploy funds into existing portfolio companies to help them accelerate their growth.

The Board thanks new and existing shareholders for their support in the recent fundraising and look forward to updating shareholders on progress deploying these funds over the coming quarters.

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

16 June 2023

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFGPUWPQUPWGUQ
Date   Source Headline
22nd Jun 20264:33 pmRNSTransaction in Own Shares
22nd Jun 20269:50 amRNSPayment of dividend and issue of equity
11th Jun 202612:15 pmRNSInterim Management Statement to 31 March 2026
9th Jun 20261:50 pmRNSResult of AGM
6th May 20267:00 amRNSDividend Declaration
20th Apr 202610:01 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:12 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNSAnnual Financial Report
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:31 amRNSDirector/PDMR Shareholding
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSInterim Management Statement
20th Nov 20259:00 amRNSOffer Update
31st Oct 202510:01 amRNSPayment of dividend and issue of Equity
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSHalf-year Report
22nd Aug 202510:45 amRNSNew combined offer for subscription
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 202510:20 amRNSPayment of Dividend and Issue of Equity
13th Jun 20251:30 pmRNSInterim Management Statement
12th Jun 202510:46 amRNSResult of AGM
13th May 202512:54 pmRNSDividend Declaration
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:15 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNSAnnual Financial Report
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:21 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
17th Dec 20242:13 pmRNSNominal Capital Reduction
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:08 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNS3rd Quarter Results
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.